Clinical Trial Update: A Study of AT132 in Young Children With X-Linked Myotubular Myopathy (XLMTM) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting results for AT132 in young children with X-Linked Myotubular Myopathy across Phase 2 and Phase 3, with results posted in 2024 an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• X-linked Myotubular Myopathy

Drugs mentioned

• AT132

Snippet

Sponsor: Astellas Gene Therapies | Conditions: X-Linked Myotubular Myopathy | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-08-20